It should also be noted that while the mean liver chemistries for these three tests were higher in the AHUO group, the range in the COVID-19 group was wider for ALT and AST, with a small number of COVID-19 patients having higher levels of these enzymes. The gene discussed is GPT; the disease is COVID-19.